Cyclophosphamide as a first-line therapy in LGL leukemia
2013 · Leukemia · 97 citations
https://doi.org/10.1038/leu.2013.359
Z
Zainul S. Hasanali
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
537
Citations
11
h-index
11
i10-index
Zainul S. Hasanali is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders. The author has an h-index of 11, co-authored 35 publications.
ORCID: 0000-0002-9150-089XPapers by this author
worksBone marrow plasma cells require P2RX4 to sense extracellular ATP
2024 · Nature · 43 citations
https://doi.org/10.1038/s41586-024-07047-2
Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice
2024 · JCI Insight · 6 citations
https://doi.org/10.1172/jci.insight.177300
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
2025 · Journal for ImmunoTherapy of Cancer · 3 citations
https://doi.org/10.1136/jitc-2024-009349
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat